Cell-mediated immune response associated with Chlamydia pneumoniae infection in atherosclerotic patients

Loubna El Yazouli1, Fouad Seghrouchni2, Hicham Hejaji3

  • 1Institut Pasteur du Maroc, Chlamydiae and Mycoplasmas Laboratory, Casablanca, 20360, Morocco; Laboratory of Human Pathologies Biology, Genomic Center of Human Pathologies, Faculty of Sciences, Mohammed V University of Rabat, Morocco.

Microbial Pathogenesis
|November 11, 2019
PubMed

Insights

Chlamydia pneumoniae infection increases CD4, CD8, and CD14 expression in atherosclerosis patients and healthy individuals. This suggests C. pneumoniae may drive immune responses contributing to atherosclerosis development.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cardiovascular Research

Background:

  • Chlamydia pneumoniae is an intracellular bacterium linked to atherosclerosis.
  • It activates cell-mediated immune responses, suggesting a role in cardiovascular disease pathogenesis.

Purpose of the Study:

  • To investigate the cell-mediated immune response to C. pneumoniae in atherosclerosis patients.
  • To evaluate the expression of CD14, CD8, and CD4 in response to C. pneumoniae infection.

Main Methods:

  • Analyzed 27 atherosclerosis patients and 32 controls.
  • Detected C. pneumoniae DNA in peripheral blood mononuclear cells (PBMCs) using nested PCR.
  • Measured CD4, CD8, and CD14 expression via flow cytometry.

Main Results:

  • Increased mean fluorescence intensity (MFI) of CD4, CD8, and CD14 was observed in C. pneumoniae DNA-positive subjects (patients and controls).
  • Statistically significant differences (p < 0.05) were found in marker expression between C. pneumoniae DNA-positive and negative groups.
  • C. pneumoniae DNA-positive atherosclerosis patients showed significantly higher CD4, CD8, and CD14 expression compared to C. pneumoniae DNA-positive healthy controls.

Conclusions:

  • C. pneumoniae infection significantly alters cell-mediated immune responses.
  • Elevated CD4, CD8, and CD14 expression suggests a role for C. pneumoniae in atherosclerosis-related inflammation and thrombosis.
  • Further research is warranted to understand C. pneumoniae's impact on immune mechanisms in atherosclerosis.
Abstract

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
379
Inflammation01:38

Inflammation

Overview
61.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
83.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
352
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
723
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
413